Inhibition of Aromatase Activity by Sant 7 in Breast Tissue
Author Information
Author(s): Purohit A, Singh A, Ghilchik M W, Serlupi-Crescenzi O, Reed M J
Primary Institution: Imperial College, St Mary's Hospital, London, UK
Hypothesis
Can the IL-6 antagonist Sant 7 inhibit aromatase activity stimulated by IL-6 and its soluble receptor in breast tissue-derived fibroblasts?
Conclusion
Sant 7 effectively blocks IL-6+IL-6sR-stimulated aromatase activity in breast fibroblasts.
Supporting Evidence
- IL-6 alone increased aromatase activity by 27%.
- Sant 7 caused a significant decrease in basal aromatase activity.
- Sant 7 blocked IL-6+IL-6sR stimulation of aromatase activity.
- Proximal fibroblasts showed higher aromatase activity than tumor fibroblasts.
- Sant 7 reduced the ability of PGE2 to stimulate aromatase activity.
Takeaway
Sant 7 is a special medicine that can stop a certain process in breast cells that makes them produce more estrogen, which can help in treating breast cancer.
Methodology
Fibroblasts from breast tissue were cultured and treated with IL-6, IL-6sR, and Sant 7 to measure aromatase activity.
Potential Biases
Potential bias in sample selection as tissues were collected from women undergoing specific surgical procedures.
Limitations
The study primarily focused on fibroblasts from a limited number of subjects, which may not represent all breast cancer cases.
Participant Demographics
Women undergoing reduction mammoplasty and lumpectomy or mastectomy.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website